Lornng/cpgQA huggingface dataset:
Features and overview

As part of the patient-centered care approach, clinicians should review the patient’s history including previous treatment approaches, their results, and any other outcomes with the patient. They should ask the patient about his or her willingness to accept a referral to an addiction or other behavioral health specialist when appropriate. Lastly, they should involve the patient in prioritizing problems to be addressed and in setting specific goals regardless of the selected setting or level of care. The below approach may be used in setting SMART (Specific, Measurable, Action Oriented, Realistic, Timed) goals for the patient (Table 1).

Question: What should the clinicians do as part of the patient-centered care approach?
Answer: review the patient’s history including previous treatment approaches, their results, and any other outcomes with the patient

Question: What should the clinicians ask the patient?
Answer: about his or her willingness to accept a referral to an addiction or other behavioral health specialist when appropriate
Features and overview

The shared decision making process for chronic pain treatment planning is based on the foundation of a  patient-centered assessment of risks and benefits and a clinical synthesis performed by the provider  (Figure 1). The patient-centered assessment incorporates a patient-centered interview, and exploration of  patient values, goals, questions, concerns, and expectations. Next, the clinician performs a biopsychosocial  assessment and determines clinically appropriate therapeutic options in which benefits are likely to  outweigh risks. The process culminates in a shared decision making process to develop a patient-centered  treatment plan by the patient selecting from the clinically appropriate treatment options generated in the  first two steps.

Question: What is the basis of the shared decision making process for chronic pain treatment planning?
Answer: the foundation of a  patient-centered assessment of risks and benefits and a clinical synthesis performed by the provider

Question: What does the patient-centered assessment incorporate?
Answer: a patient-centered interview, and exploration of  patient values, goals, questions, concerns, and expectations
Features and overview

There are electronic tools to facilitate clinical risk assessment and adherence to risk mitigation. Two tools  currently used in the VA are the Opioid Therapy Risk Report (OTRR) and the Stratification Tool for  Opioid Risk Mitigation (STORM). The OTRR allows VA providers to review clinical data related to opioid  pain treatment within the electronic medical record (EMR), providing an efficient way of monitoring the  data. The STORM tool incorporates co-occurring medical and mental health conditions, SUD, opioid dose,  co-prescribed sedatives, and information about prior adverse events and generates estimates of patients’  risk or hypothetical risk when considering initiation of opioid therapy. It quantifies risk for poisoning or  suicide-related events and for drug-related events, accidents, falls, and drug-induced conditions over a  three-year window. Further, it provides suggestions as to what alternative treatments have not been tried  and what risk mitigation strategies need to be applied. Evidence supporting their use is poor but they  facilitate providers’ determination of current, past and potential therapies and strategies.

Question: What can facilitate clinical risk assessment and adherence to risk mitigation?
Answer: There are electronic tools

Question: Which electronic tools are currently used in the VA?
Answer: the Opioid Therapy Risk Report (OTRR) and the Stratification Tool for  Opioid Risk Mitigation (STORM)

Question: What does the OTRR do?
Answer: allows VA providers to review clinical data related to opioid  pain treatment within the electronic medical record (EMR), providing an efficient way of monitoring the  data

Question: What does the STORM tool do?
Answer: incorporates co-occurring medical and mental health conditions, SUD, opioid dose,  co-prescribed sedatives, and information about prior adverse events and generates estimates of patients’  risk or hypothetical risk when considering initiation of opioid therapy. It quantifies risk for poisoning or  suicide-related events and for drug-related events, accidents, falls, and drug-induced conditions over a  three-year window. Further, it provides suggestions as to what alternative treatments have not been tried  and what risk mitigation strategies need to be applied.